-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508. Bone Marrow Failure: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Anemias, antibodies, autoimmune disorders, Biological, HSCs, therapy sequence, aplastic anemia, Diseases, Bone Marrow Failure, Combinations, Diamond Blackfan Anemia, platelets, Therapies, Pediatric, red blood cells, Biological Processes, white blood cells, Immune Disorders, PNH, Cell Lineage, epigenetics, immunotherapy, Study Population, Clinically relevant, hematopoiesis, immune mechanism, transplantation, metabolomics, pathogenesis
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Benjamin F Frost1,2*, Jamie Duke, PhD3*, Hongbo Xie, PhD4*, Deborah Ferriola, BSc3*, Joseph H Oved, MD, MA1, Peter Nicholas, BA1,5*, Jian-Meng Fan, BS6*, Ryan Hausler, MS2*, Alison A. Bertuch, MD, PhD7, Elissa M. Furutani, MD8, Akiko Shimamura, MD, PhD9, Stephanie J. Lee, MD, MPH10,11, Stephen R. Spellman, MS10*, Dimitri S. Monos, PhD3*, Timothy S. Olson, MD, PhD1,5 and Daria V. Babushok, MD, PhD1,12

1Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA
2Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
3Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
5Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
6Comprehensive Bone Marrow Failure Center, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
7Department of Pediatrics, Hematology/Oncology, Baylor College of Medicine, Houston, TX
8Boston Children's Cancer and Blood Disorders Center, Boston Children’s Hospital, Boston, MA
9Dana-Farber/Boston Children's Cancer & Blood Disorders Center, Harvard Medical School, Boston, MA
10CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
11Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
12Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Merion Station, PA

Yihong Guan, PhD1*, Metis Hasipek, PhD1*, Bhumika J. Patel, MD2, Dale Grabowski, BS3*, Anand D. Tiwari, PhD1*, Sunisa Kongkiatkamon, MD1*, Cassandra M Kerr, MS1*, Aziz Nazha, MD4, Yogenthiran Saunthararajah, MD1, Mikkael A. Sekeres, MD, MS5, Jaroslaw P. Maciejewski, MD, PhD5 and Babal K. Jha, PhD1*

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland
4Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Mark C Wilkes, PhD1, Hee-Don Chae, PhD1*, Ethan Patrick Wentworth1*, Toshinobu Nishimura, PhD2*, Anupama Narla, MD1, Bertil Glader, MD, PhD1, Hiromitsu Nakauchi2*, Joanna Wysocka2* and Kathleen M. Sakamoto, MD, PhD1

1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
2Institute for Stem Cell Biology and Genetics, Department of Genetics, Stanford University, Stanford, CA

Raynier Devillier1,2,3*, Dirk-Jan Eikema4*, Paul Bosman5*, Carlo Dufour6,7, Mahmoud Aljurf8, Depei Wu, MD, PhD9, Alexey Maschan, MD10, Boris V. Afanasyev11*, Constantijn Halkes12, Matthew P. Collin, MD, PhD13, John A Snowden, BSc (Hons), MBChB, MD, FRCP, FRCPath14, Yves Bertrand, M.D.15*, Arnold Ganser16, Karl-Walter Sykora, MD17*, Brenda Gibson, MD, PhD18*, Johan Maertens19*, Maija Itälä-Remes, MD, PhD20*, Corti Paola21*, Jan J. Cornelissen, MD, PhD22, Martin Bornhäuser, MD23*, Mercedes Colorado Araujo24*, Hakan Ozdogu, MD25*, Antonio Risitano, MD, PhD26 and Regis Peffault De Latour, MD, PhD27,28*

1Institut Paoli Calmettes, Marseille, France
2CRCM / INSERM U1068, Marseille, France
3Aix Marseille University, Medicine Faculty, Marseille, France
4EBMT Data Office Leiden, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, Netherlands
5EBMT Data Office, Leiden, Netherlands
6Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT), Leiden, Netherlands
7Hematology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
8King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
9The First Affiliated Hosp. of Soochow University, Suzhou, Jiangsu, China
10Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
11RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
12Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
13Newcastle University, Newcastle Upon Tyne, United Kingdom
14Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom
15Institute of Pediatric Hematology and Oncology, Civil Hospital of Lyon, Claude Bernard University, Lyon, France
16Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Medizinische Hochschule Hannover, Hannover, Germany
17Pediatric Hematology and Oncology, Hannover Medical School, Hanover, Germany
18Department of Hematology, Royal Hospital for Children, Glasgow, GBR
19University Hospital Gasthuisberg, Leuven, Belgium
20Turku University Hospital, Stem cell transplantation unit, Turku, Finland
21Ematologia Pediatrica, Ospedale San Gerardo, Monza, Italy
22Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
23Department of Hematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
24Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia, Santander, Spain
25Hematology, Baskent University, Adana, Turkey
26Department of Clinical Medicine and Surgery, University of Naples, Naples, Italy
27French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Assistance Publique – Hôpitaux de Paris, Université de Paris, Paris, France
28Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation, Leiden, Netherlands

Nan of Wang, PhD1*, Corinne Marie Lavasseur, BA2*, Hongxia Yan, MS3*, Scott Younger, PhD4*, Bertil Glader, MD, PhD5,6, Kathleen M. Sakamoto, MD, PhD7, Lionel Blanc, PhD8,9 and Anupama Narla, MD7,10,11

1Department of Pediatrics - Division of Hematology/Oncology, Stanford University School of Medicine, Palo Alto, CA
2School of Medicine, Case Western Reserve Universiyt, Cleveland, OH
3Laboratory of Red Cell Physiology, New York Blood Center, New York, NY
4Children's Mercy Kansas City, Children's Mercy Research Institute, Kansas City, MO
5Department of Pediatrics, Division of Hematology/Oncology, Stanford University School of Medicine, Stanford, CA
6Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA
7Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
8Feinstein Institute for Medical Research, Manhasset, NY
9The Feinstein Institutes For Medical Research, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY
10Stanford University, Stanford, CA
11Stanford University, Hillsborough, CA

Jun-ichi Nishimura, MD, PhD1, Kensuke Usuki, MD, PhD2, Julia Ramos, MD, PhD3,4, Satoshi Ichikawa, MD, PhD5*, Jules Hernández-Sánchez, PhD6*, Anna Kiialainen, PhD6*, Alexandre Sostelly, PhD6*, Regis Peffault De Latour, MD, PhD7*, Ido Paz-Priel, MD4 and Alexander Röth, MD8

1Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
2Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
3Division of Hematology and Oncology, University of California, San Francisco, CA
4Genentech, Inc., South San Francisco, CA
5Department of Hematology and Rheumatology, Tohoku University Hospital, Miyagi, Japan
6F. Hoffmann-La Roche Ltd, Basel, Switzerland
7CHU Paris GH St Louis Lariboisiere F Widal Hospital, Paris, France
8Department of Hematology, University Hospital Essen, Essen, Germany

Regis Peffault De Latour, MD, PhD1*, Simona Sica, MD, PhD2,3*, Julia Ramos, MD4,5, Jules Hernández-Sánchez, PhD6*, Jin Seok Kim, MD, PhD7*, Anna Kiialainen, PhD6*, Sung-Soo Yoon, MD, PhD8, Sasha Sreckovic, MD6, Antoine Soubret, PhD6*, Haruhiko Ninomiya, MD, PhD9, Alexandre Sostelly, PhD6*, Jens Panse, MD10, Simon Buatois, PharmD, PhD6*, Hubert Schrezenmeier11, Ido Paz-Priel, MD12, Jun-ichi Nishimura, MD, PhD13 and Alexander Röth, MD14

1CHU Paris GH St Louis Lariboisiere F Widal Hospital, Paris, France
2Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universita’ Cattolica del Sacro Cuore, Rome, Italy
3Dipartimento di Diagnositica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Agostino Gemelli IRCSS, Rome, Italy
4Division of Hematology and Oncology, University of California, San Francisco, CA
5Genentech, Inc., South San Francisco, CA
6F. Hoffmann-La Roche Ltd, Basel, Switzerland
7Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
8Seoul National University Hospital, Seoul, Korea, Republic of (South)
9Medical Sciences, University of Tsukuba, Tsukuba, Japan
10University Hospital RWTH Aachen, Aachen, Germany
11Institute of Clinical Transfusion Medicine and Immunogenetics, University of Ulm, Ulm, Germany
12Genentech, Inc., South San Fransisco, CA
13Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
14Department of Hematology, University Hospital Essen, Essen, Germany

Birgit Van Dooijeweert, MD1,2*, Melissa H. Broeks, MSc3*, Simon T. Grootendorst, MSc4*, Nanda M. Verhoeven, PhD, Professor5*, Wouter W. van Solinge, PhD, Professor6*, Edward E.S. Nieuwenhuis, MD, PhD, Professor2*, Judith J. Jans, PhD5*, Richard van Wijk, PhD4* and Marije Bartels, MD, PhD2,7*

1Central Diagnostic Laboratory Research Department, University Medical Center Utrecht, Utrecht, Utrecht, Netherlands
2Department of Pediatric Hematology, University Medical Center Utrecht, Utrecht, Netherlands
3Department of Genetics, Section Metabolic Diagnostics, University Medical Center Utrecht, Utrecht, NLD
4Central Diagnostic Laboratory Research Department, University Medical Center Utrecht, Utrecht, Netherlands
5Department of Genetics, Section Metabolic Diagnostics, University Medical Center Utrecht, Utrecht, Netherlands
6Central Diagnostic Laboratory Research Department, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
7Van Creveldkliniek, University Medical Center Utrecht, Utrecht, Netherlands

Mohammed Al Nuaimi, MD, BSc, FRCPC1*, Evelyn Elias, MSc1*, Albert Catala, MD, PhD1*, Bozana Zlateska, MD, MSc2*, Yeon Jung Lim, MD3*, Robert J Klaassen, MD, FRCPC4, Geoff D.E. Cuvelier, MD5, Conrad Fernandez, FRCPC, MD, BSc6, Meera Rayar7*, MacGregor Steele, MD, FRCPC8, Sharon Abish, MD9, Yves D. Pastore, MD10, Vicky R. Breakey, BSc, MEd, FRCPC11, Soumitra Tole, MD, MSc12, Josee Brossard, MD13*, Roona Sinha, MD14, Mariana Silva, MD, FRCPC15, Lisa Goodyear, MD, FRCPC16*, Jeffrey H. Lipton, MD, PhD17, Bruno Michon, MD, FRCPC18*, Catherine Corriveau-Bourque, MD19, Lillian Sung, MD, PhD20, Yigal Dror, MD, FRCPC1 and Michaela Cada, MD, FRCPC, FAAP, MPH1

1Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada
2Department of Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada
3Program in Genetics and Genome Biology, Research Institute, Hospital for Sick Children, Toronto, Canada
4Children's Hospital of Eastern Ontario, Ottawa, ON, Canada
5Pediatric Blood and Marrow Transplant, Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada
6Pediatric Hematology/Oncology, IWK Health Center, Halifax, NS, Canada
7British Columbia Children’s Hospital, Vancouver, Canada
8Cumming School of Medicine, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada
9Pediatric Hematology Oncology, Montreal Children's Hospital, Montreal, QC, Canada
10CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada
11McMaster Children's Hospital, Hamilton, ON, Canada
12Children's Hospital, London Health Sciences Centre, London, ON, Canada
13Centre hospitalier universitaire, Sherbrooke, QC, Canada
14Jim Pattison Children’s Hospital, Saskatoon, SK, Canada
15Kingston General Hospital, Queen’s University, Kingston, ON, Canada
16Janeway Child Health Centre, St. John's, Canada
17Hans Messner Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
18Division of Hematology-Oncology, Centre Hospitalier de l'Universite Laval (CHUL), Quebec, QC, Canada
19Division of Pediatric Hematology, Oncology and BMT, University of Alberta, Stollery Children's Hospital, Edmonton, AB, Canada
20Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada

Simon Buatois, PharmD, PhD*, Alexandre Sostelly, PhD*, Antoine Soubret, PhD*, Felix Jaminion* and Valerie Cosson, PhD*

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Rong Fu, PhD1*, Shaoxue Ding, MD1*, Xiaowei Liang1*, Tian Zhang2* and Zonghong Shao, PhD3

1Tianjin Medical University General Hospital, Tianjin, China
2Tianjin Medical University Genernal Hospital, Tianjin, China
3Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China

Lang Cheng1*, Run Zhang2*, Qi Gao3*, Haili Ma3*, Heng Liu3*, Guangsheng He, Prof.Dr.4,5* and Jianyong Li, MD, PhD6,7

1Department of hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
2Department of hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital., NanJing, China
3LongBio Pharma, ShangHai, China
4Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital., Nanjing, China
5Hematology, Jiangsu Province Hospital, Nanjing, China
6Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
7Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Kazuhiro Sabet, MD1* and Arun Ranjan Panigrahi, MD2

1UC Davis Children's Hospital, Sacramento, CA
2Pediatric Hematology/Oncology, UC Davis Children's Hospital, Sacramento, CA

*signifies non-member of ASH